French Pharma Firm Transgene Utilizes Blockchain to Track Clinical Trials
In a recent press release, French biopharmaceutical firm Transgene announced its integration with blockchain supply chain traceability solution Hypertrust-X Chain for Clinical Trials for its individualized therapeutic vaccine against ovarian, head, and neck cancer to provide an immutable audit trail throughout the treatment process.
Hypertrust X-Chain to Track Clinical Trials
In a bid to leverage the benefits of distributed ledger technology (DLT) to make its clinical trials process more transparent, Transgene has implemented Hypertrust Patient Data Care’s blockchain supply chain traceability product into its clinical trials project dubbed myvac.
For the uninitiated, myvac is Transgene’s viral vector-based, individualized immunotherapy platform that targets solid tumors. Transgene is using myvac to develop individualized immunotherapy products by analyzing cells from individuals and using unique patient-specific mutations to develop a tailored vaccine that aids the immune system to defend itself against cancer cells.
Understandably, this process is extremely delicate and mandates the need for tamper-proof data all along the supply chain. The involvement of multiple companies throughout the process further makes the need for legitimate data all the more crucial.
Blockchain solves this by offering a decentralized source of data, thereby providing a high level of trust and transparency with regard to how data was collected and modified all along the supply chain. The technology also shields the confidential patient data from possible cyber attacks.
Commenting on the development, Eric Quéméneur, Executive VP, Chief Scientific Officer, Transgene, said:
“We have set up multiple collaborations around the world to allow each patient’s anticancer therapy to be designed in a timely manner. Blockchain technologies are a perfect tool to ensure that the patient’s genetic data are protected while ensuring that all the interventions of our partners are both smooth and tracked. We were very happy to collaborate with Hypertrust and together set up this novel process, demonstrating once again Transgene’s ability to be at the forefront of innovation.”
Hypertrust’s X-Chain platform securely stores all data gathered along the supply chain on a blockchain. Later, the platform shares the required details of data with stakeholders via smart contracts, ensuring the utmost safety and traceability.
Blockchain in Pharma
The use of blockchain technology has experienced upward traction in the pharma industry, especially in its supply chain infrastructure that has been marred by the COVID-19 pandemic.
As previously reported by BTCManager, California-based DLT project HashCash Consultants is considering inking partnerships with several pharma firms and medical goods manufacturers to bring more transparency to their supply chain fabric.
Similarly, on May 28, BTCManager reported that supply chain-focused blockchain project VeChain had partnered with Bayer China to improve the management of clinical trial drugs.